Study at HCA Healthcare Hospitals Shows Significant Reduction in Bloodstream Infections

Dateline City:


Large-scale trial conducted at 53 HCA Healthcare hospitals involving 330,000 patients

NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare (NYSE: HCA), a leading healthcare provider with 185
hospitals and more than 1,800 sites of care in 20 states and the United
Kingdom, today announced a study published in the current issue of The
Lancet and conducted exclusively at HCA Healthcare hospitals has
shown an infection control technique achieved a 31 percent reduction in
bloodstream infections and nearly a 40 percent reduction in
antibiotic-resistant bacteria among non-ICU patients with central line
catheters and lumbar drains.




Investor Contact: Mark Kimbrough615-344-2688 Media Contact: Ed Fishbough615-344-2810

Ticker Slug:

Ticker: HCA Exchange: NYSE

read more

Original Source